- Home
- APLS vs GMS Comparison
APLS vs GMS Comparison
Compare APLS & GMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLS
- GMS
- Stock Information
- Founded
- APLS 2009
- GMS 1971
- Country
- APLS United States
- GMS United States
- Employees
- APLS N/A
- GMS N/A
- Industry
- APLS Biotechnology: Pharmaceutical Preparations
- GMS
- Sector
- APLS Health Care
- GMS
- Exchange
- APLS Nasdaq
- GMS Nasdaq
- Market Cap
- APLS 4.4B
- GMS 3.9B
- IPO Year
- APLS 2017
- GMS 2016
- Fundamental
- Price
- APLS $27.75
- GMS $99.19
- Analyst Decision
- APLS Buy
- GMS Buy
- Analyst Count
- APLS 19
- GMS 8
- Target Price
- APLS $49.89
- GMS $91.50
- AVG Volume (30 Days)
- APLS 4.0M
- GMS 320.5K
- Earning Date
- APLS 11-05-2024
- GMS 12-05-2024
- Dividend Yield
- APLS N/A
- GMS N/A
- EPS Growth
- APLS N/A
- GMS N/A
- EPS
- APLS N/A
- GMS 6.07
- Revenue
- APLS $715,216,000.00
- GMS $5,540,763,000.00
- Revenue This Year
- APLS $95.59
- GMS $4.35
- Revenue Next Year
- APLS $13.77
- GMS $3.36
- P/E Ratio
- APLS N/A
- GMS $16.40
- Revenue Growth
- APLS 162.10
- GMS 3.00
- 52 Week Low
- APLS $24.34
- GMS $65.46
- 52 Week High
- APLS $73.80
- GMS $103.56
- Technical
- Relative Strength Index (RSI)
- APLS 47.09
- GMS 59.08
- Support Level
- APLS $25.76
- GMS $97.98
- Resistance Level
- APLS $30.80
- GMS $100.53
- Average True Range (ATR)
- APLS 1.84
- GMS 2.19
- MACD
- APLS 0.04
- GMS -0.05
- Stochastic Oscillator
- APLS 52.79
- GMS 65.59
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.
About GMS GMS Inc.
GMS Inc is a distributor of specialty building products including wallboard, suspended ceiling systems, ceilings, steel framing, and other complementary building products. The company serves its products to commercial new construction, commercial repair and remodel, residential new construction, and residential repair and remodel (R&R). Its geographical segment is Central, Midwest, New York, Northeast, Southern, Southeast, Southwest, Western and Canada, and Ames. The company generates maximum revenue from Wallboard products.